author-photo

Li Bai

Chinese General Hospital College of Nursing and Liberal Arts

1

Papers

3

Citations

Citation Trend

Filter By

Papers (1) Sort By

Journal Conference Others

Phase 2 study of AK104 (PD-1/CTLA-4 bispecific antibody) plus lenvatinib as first-line treatment of unresectable hepatocellular carcinoma.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)